Path: ...!feeds.phibee-telecom.net!newsreader4.netcologne.de!news.netcologne.de!peer03.ams1!peer.ams1.xlned.com!news.xlned.com!peer02.ams4!peer.am4.highwinds-media.com!news.highwinds-media.com!fx16.ams4.POSTED!not-for-mail
MIME-Version: 1.0
User-Agent: Mozilla Thunderbird
Subject: =?UTF-8?Q?Re=3A_ARN=2C_antibiotiques_=3A_les_r=C3=A9v=C3=A9lations_?=
 =?UTF-8?Q?exclusives_du_professeur_Raoult_!?=
Content-Language: fr
Newsgroups: fr.soc.politique,fr.bio.medecine
References: <65a58b8a$0$2566$426a74cc@news.free.fr>
 <uo44fd$12hvt$1@dont-email.me> <65a59a86$0$16352$426a74cc@news.free.fr>
 <uo48nm$137pl$1@dont-email.me> <65a5b119$0$29751$426a74cc@news.free.fr>
 <uo4f7c$1454a$1@dont-email.me> <WvupN.214573$cRu4.137926@fx04.ams4>
 <uo5sm8$1e15h$1@dont-email.me> <DXupN.106236$ee1.35682@fx16.ams4>
 <uo65sl$1g642$1@dont-email.me> <mAApN.129806$ee1.111633@fx16.ams4>
 <uo6vv8$1kss1$1@dont-email.me> <6iPpN.174479$ee1.98058@fx16.ams4>
 <65a828f2$0$6455$426a74cc@news.free.fr> <uo9jq5$27fe5$1@dont-email.me>
 <65a8f17a$0$6425$426a34cc@news.free.fr> <uob1p7$2ik24$1@dont-email.me>
 <65a9896b$0$11901$426a74cc@news.free.fr> <uocfnq$2qbb8$1@dont-email.me>
 <lJrqN.558135$ee1.140864@fx16.ams4> <l0v05pFtb55U2@mid.individual.net>
 <IRsqN.622932$ee1.33521@fx16.ams4> <uodpe5$34mbf$1@dont-email.me>
From: Paul Aubrin <paul.aubrin@invalid.org>
In-Reply-To: <uodpe5$34mbf$1@dont-email.me>
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Lines: 8
Message-ID: <j7vqN.664199$ee1.562776@fx16.ams4>
X-Complaints-To: abuse@eweka.nl
NNTP-Posting-Date: Fri, 19 Jan 2024 13:51:11 UTC
Organization: Eweka Internet Services
Date: Fri, 19 Jan 2024 14:51:11 +0100
X-Received-Bytes: 1911
Bytes: 2059

Le 19/01/2024 à 13:20, Olivier@ a écrit :
> Paul Aubrin a couché sur son écran :
> 
>> Si on avait admis que l'HCQ, ou l'ivermectine, ou un autre produit 
>> réduisait le risque, 
> 
> Impossible car non prouvé.
https://www.cjoint.com/data/NAqtlhZVPGR_c19hcq-org.png